Function Health continued to build out its preventive health platform this week, combining strategic expansion with focused educational outreach. The company completed the acquisition of SuppCo, an independent supplement intelligence provider, and amplified content around comprehensive diagnostics and women’s metabolic health.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
The SuppCo deal brings a large supplement database, a TrustScore rating system, and an ISO 17025–based TESTED program into Function Health’s ecosystem. By integrating these assets with more than 160 lab tests and optional MRI and CT imaging, Function aims to close the loop between biological measurement, consumer inputs, and targeted interventions.
Function plans to fold SuppCo’s app and testing infrastructure into its AI health operating system, enabling members to track lab trends, imaging results, and supplement effects in a single interface. Leadership positions this as a way to strip away marketing noise in the supplement market and provide brand-agnostic, evidence-based recommendations.
The acquisition also adds a roster of venture investors backing SuppCo, including Greylock and Union Square Ventures, potentially enhancing Function’s partnership and capital networks. Management expects the combined capabilities to increase member lifetime value and open new monetization opportunities around personalized health protocols.
On the clinical education front, Function highlighted evolving thinking around Polycystic Ovary Syndrome, reframing it as Polyendocrine Metabolic Ovarian Syndrome. The company emphasized that an AMH blood test may offer a less invasive diagnostic pathway than transvaginal ultrasound, aligning with its focus on accessible, lab-driven women’s health solutions.
Function further reinforced its broader preventive wellness positioning through marketing content on metabolic and hormone testing. Recent communications spotlighted biomarkers such as insulin, cortisol, thyroid hormones, and leptin, and tied them to weight management and lifestyle factors while clearly labeling materials as non-medical advice.
Collectively, the week’s developments underscore Function Health’s push to evolve from a diagnostics subscription service into an integrated health operating layer that connects data, education, and actionable guidance. If execution is successful, these moves could deepen user engagement, expand the addressable market, and strengthen the company’s competitive position in personalized preventive care.

